Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.09
AMS's Cash to Debt is ranked lower than
74% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 0.31 vs. AMS: 0.09 )
Ranked among companies with meaningful Cash to Debt only.
AMS' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 0.27 Max: 1.04
Current: 0.09
0
1.04
Equity to Asset 0.35
AMS's Equity to Asset is ranked lower than
65% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. AMS: 0.35 )
Ranked among companies with meaningful Equity to Asset only.
AMS' s Equity to Asset Range Over the Past 10 Years
Min: -0.34  Med: 0.32 Max: 0.43
Current: 0.35
-0.34
0.43
Interest Coverage 1.33
AMS's Interest Coverage is ranked lower than
89% of the 157 Companies
in the Global Medical Care industry.

( Industry Median: 9.36 vs. AMS: 1.33 )
Ranked among companies with meaningful Interest Coverage only.
AMS' s Interest Coverage Range Over the Past 10 Years
Min: 0.32  Med: 0.62 Max: 1.79
Current: 1.33
0.32
1.79
F-Score: 4
Z-Score: 0.52
M-Score: -3.49
WACC vs ROIC
10.05%
2.89%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) 9.95
AMS's Operating margin (%) is ranked higher than
61% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 7.46 vs. AMS: 9.95 )
Ranked among companies with meaningful Operating margin (%) only.
AMS' s Operating margin (%) Range Over the Past 10 Years
Min: -0.32  Med: 6.76 Max: 19.04
Current: 9.95
-0.32
19.04
Net-margin (%) -10.63
AMS's Net-margin (%) is ranked lower than
88% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 4.28 vs. AMS: -10.63 )
Ranked among companies with meaningful Net-margin (%) only.
AMS' s Net-margin (%) Range Over the Past 10 Years
Min: -6.18  Med: 1.31 Max: 9.69
Current: -10.63
-6.18
9.69
ROE (%) -8.44
AMS's ROE (%) is ranked lower than
88% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 9.24 vs. AMS: -8.44 )
Ranked among companies with meaningful ROE (%) only.
AMS' s ROE (%) Range Over the Past 10 Years
Min: -4.64  Med: 1.36 Max: 9.85
Current: -8.44
-4.64
9.85
ROA (%) -2.87
AMS's ROA (%) is ranked lower than
82% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 3.51 vs. AMS: -2.87 )
Ranked among companies with meaningful ROA (%) only.
AMS' s ROA (%) Range Over the Past 10 Years
Min: -1.37  Med: 0.41 Max: 3.68
Current: -2.87
-1.37
3.68
ROC (Joel Greenblatt) (%) 1.43
AMS's ROC (Joel Greenblatt) (%) is ranked lower than
78% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 20.18 vs. AMS: 1.43 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
AMS' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 2.18  Med: 6.18 Max: 13.22
Current: 1.43
2.18
13.22
Revenue Growth (3Y)(%) -14.00
AMS's Revenue Growth (3Y)(%) is ranked lower than
89% of the 160 Companies
in the Global Medical Care industry.

( Industry Median: 8.20 vs. AMS: -14.00 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
AMS' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -44.3  Med: 1.85 Max: 27.8
Current: -14
-44.3
27.8
EBITDA Growth (3Y)(%) -12.10
AMS's EBITDA Growth (3Y)(%) is ranked lower than
87% of the 128 Companies
in the Global Medical Care industry.

( Industry Median: 7.90 vs. AMS: -12.10 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
AMS' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -34.3  Med: 0.15 Max: 18.4
Current: -12.1
-34.3
18.4
» AMS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with AMS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 0.47
AMS's P/B is ranked higher than
98% of the 302 Companies
in the Global Medical Care industry.

( Industry Median: 2.69 vs. AMS: 0.47 )
Ranked among companies with meaningful P/B only.
AMS' s P/B Range Over the Past 10 Years
Min: 0.26  Med: 0.67 Max: 1.99
Current: 0.47
0.26
1.99
P/S 0.61
AMS's P/S is ranked higher than
78% of the 303 Companies
in the Global Medical Care industry.

( Industry Median: 1.26 vs. AMS: 0.61 )
Ranked among companies with meaningful P/S only.
AMS' s P/S Range Over the Past 10 Years
Min: 0.24  Med: 0.78 Max: 2.02
Current: 0.61
0.24
2.02
PFCF 4.65
AMS's PFCF is ranked higher than
96% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 19.92 vs. AMS: 4.65 )
Ranked among companies with meaningful PFCF only.
AMS' s PFCF Range Over the Past 10 Years
Min: 0.86  Med: 2.56 Max: 56
Current: 4.65
0.86
56
POCF 1.16
AMS's POCF is ranked higher than
99% of the 273 Companies
in the Global Medical Care industry.

( Industry Median: 14.37 vs. AMS: 1.16 )
Ranked among companies with meaningful POCF only.
AMS' s POCF Range Over the Past 10 Years
Min: 0.59  Med: 1.83 Max: 4.56
Current: 1.16
0.59
4.56
EV-to-EBIT 43.59
AMS's EV-to-EBIT is ranked lower than
88% of the 294 Companies
in the Global Medical Care industry.

( Industry Median: 17.86 vs. AMS: 43.59 )
Ranked among companies with meaningful EV-to-EBIT only.
AMS' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.7  Med: 12.65 Max: 67.6
Current: 43.59
6.7
67.6
EV-to-EBITDA 4.74
AMS's EV-to-EBITDA is ranked higher than
97% of the 302 Companies
in the Global Medical Care industry.

( Industry Median: 12.26 vs. AMS: 4.74 )
Ranked among companies with meaningful EV-to-EBITDA only.
AMS' s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.8  Med: 4.90 Max: 6.7
Current: 4.74
2.8
6.7
Shiller P/E 49.03
AMS's Shiller P/E is ranked lower than
80% of the 69 Companies
in the Global Medical Care industry.

( Industry Median: 28.10 vs. AMS: 49.03 )
Ranked among companies with meaningful Shiller P/E only.
AMS' s Shiller P/E Range Over the Past 10 Years
Min: 3.2  Med: 10.96 Max: 55
Current: 49.03
3.2
55
Current Ratio 0.73
AMS's Current Ratio is ranked lower than
76% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 1.33 vs. AMS: 0.73 )
Ranked among companies with meaningful Current Ratio only.
AMS' s Current Ratio Range Over the Past 10 Years
Min: 0.36  Med: 1.50 Max: 4.13
Current: 0.73
0.36
4.13
Quick Ratio 0.73
AMS's Quick Ratio is ranked lower than
72% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 1.22 vs. AMS: 0.73 )
Ranked among companies with meaningful Quick Ratio only.
AMS' s Quick Ratio Range Over the Past 10 Years
Min: 0.36  Med: 1.50 Max: 4.13
Current: 0.73
0.36
4.13
Days Sales Outstanding 76.91
AMS's Days Sales Outstanding is ranked lower than
82% of the 187 Companies
in the Global Medical Care industry.

( Industry Median: 45.70 vs. AMS: 76.91 )
Ranked among companies with meaningful Days Sales Outstanding only.
AMS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 75.57  Med: 79.09 Max: 93.87
Current: 76.91
75.57
93.87
Days Payable 16.60
AMS's Days Payable is ranked lower than
81% of the 144 Companies
in the Global Medical Care industry.

( Industry Median: 42.47 vs. AMS: 16.60 )
Ranked among companies with meaningful Days Payable only.
AMS' s Days Payable Range Over the Past 10 Years
Min: 7.13  Med: 14.08 Max: 55.09
Current: 16.6
7.13
55.09

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 0.49
AMS's Price/Tangible Book is ranked higher than
98% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 4.11 vs. AMS: 0.49 )
Ranked among companies with meaningful Price/Tangible Book only.
AMS' s Price/Tangible Book Range Over the Past 10 Years
Min: 0.27  Med: 0.75 Max: 1.83
Current: 0.49
0.27
1.83
Price/Projected FCF 0.19
AMS's Price/Projected FCF is ranked higher than
99% of the 173 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. AMS: 0.19 )
Ranked among companies with meaningful Price/Projected FCF only.
AMS' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.15  Med: 0.40 Max: 1.02
Current: 0.19
0.15
1.02
Price/Median PS Value 0.78
AMS's Price/Median PS Value is ranked higher than
90% of the 299 Companies
in the Global Medical Care industry.

( Industry Median: 1.06 vs. AMS: 0.78 )
Ranked among companies with meaningful Price/Median PS Value only.
AMS' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.15  Med: 1.07 Max: 4.8
Current: 0.78
0.15
4.8
Earnings Yield (Greenblatt) (%) 2.29
AMS's Earnings Yield (Greenblatt) (%) is ranked lower than
70% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 4.40 vs. AMS: 2.29 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
AMS' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 1.5  Med: 7.90 Max: 15
Current: 2.29
1.5
15
Forward Rate of Return (Yacktman) (%) 38.69
AMS's Forward Rate of Return (Yacktman) (%) is ranked higher than
98% of the 98 Companies
in the Global Medical Care industry.

( Industry Median: 10.04 vs. AMS: 38.69 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
AMS' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 1.6  Med: 19.05 Max: 56.7
Current: 38.69
1.6
56.7

More Statistics

Revenue(Mil) $16
EPS $ -0.32
Beta0.19
Short Percentage of Float0.11%
52-Week Range $1.50 - 2.86
Shares Outstanding(Mil)5.36

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:AZS.Germany,
American Shared Hospital Services was incorporated in the State of California in 1983 and its predecessor, Ernest A. Bates, M.D., Ltd. (d/b/a American Shared Hospital Services), a California limited partnership, was formed in June 1980. It provides Gamma Knife stereotactic radiosurgery equipment and radiation therapy and related equipment to seventeen (17) medical centers in sixteen (16) states in the United States and two medical centers in Turkey, as of March 1, 2013. The Gamma Knife stereotactic radiosurgery is a non-invasive procedure and an alternative to conventional brain surgery or can be an adjunct to conventional brain surgery, radiation therapy, or chemotherapy. Compared to conventional surgery, Gamma Knife radiosurgery usually involves shorter patient hospitalization, lower risk of complications and can be provided at a lower cost. Typically, Gamma Knife patients resume their pre-surgical activities one or two days after treatment. The Gamma Knife treats patients with 201 single doses of gamma rays that are focused with great precision on small and medium sized, well circumscribed and critically located structures in the brain. During 2006 Elekta introduced a new Gamma Knife model, the Perfexion unit, which treats patients with 192 single doses of gamma rays and will also provide the ability to perform procedures on areas of the upper cervical spine. The Gamma Knife delivers a concentrated dose of gamma rays from Cobalt-60 sources housed in the Gamma Knife. The Cobalt-60 sources converge at the target area and deliver a dose that is high enough to destroy the diseased tissue without damaging surrounding healthy tissue. The Gamma Knife treats selected malignant and benign brain tumors, arteriovenous malformations, and functional disorders including trigeminal neuralgia (facial pain). Research is being conducted to determine whether the Gamma Knife can be effective in the treatment of epilepsy and other functional disorders. Conventional neurosurgery, radiation therapy and other radiosurgery devices are the primary competitors of Gamma Knife radiosurgery. The Medicare program is administered by the Centers for Medicare and Medicaid Services of the U.S. Department of Health and Human Services.
» More Articles for AMS

Headlines

Articles On GuruFocus.com
American Shared Hospital Services: Can a Gamma Knife Generate Alpha? Apr 30 2012 
American Shared Hospital Services Reports Operating Results (10-Q) Nov 15 2010 
American Shared Hospital Services (AMS) CHAIRMAN AND CEO, 10% Owner Shared Hospital Services America Sep 14 2010 
American Shared Hospital Services Reports Operating Results (10-Q) Aug 16 2010 
American Shared Hospital Services Reports Operating Results (10-Q) May 17 2010 
American Shared Hospital Services Reports Operating Results (10-Q) Nov 16 2009 
American Shared Hospital Services Reports Operating Results (10-Q) Aug 14 2009 
American Shared Hospital Services Reports Operating Results (10-Q) May 15 2009 

More From Other Websites
South Africa's Amplats sees FY profit plunging on impairments Jan 25 2016
American Shared Hospital Services Announces Permanent Financing Package for its Orlando Proton... Jan 14 2016
Zimbabwe gives foreign firms March deadline for empowerment plans Dec 24 2015
AMSC Announces $210M Strategic Agreements With Inox Wind Limited Dec 17 2015
Diamonds are forever; is Anglo American? Dec 10 2015
AMSC Announces Improved Third Quarter Financial Outlook Dec 09 2015
AMERICAN SHARED HOSPITAL SERVICES Financials Dec 08 2015
American Shared Hospital Services Earnings Q3, 2015 Nov 23 2015
AMSC to Present at Southwest IDEAS Investor Conference on November 18 in Dallas, Texas Nov 16 2015
AMERICAN SHARED HOSPITAL SERVICES Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 12 2015
American Shared Hospital Services Reports Third Quarter Results Nov 12 2015
Q3 2015 American Shared Hospital Services Earnings Release - Time Not Supplied Nov 12 2015
American Shared Hospital Services Announces Third Quarter 2015 Results Earnings Conference Call Nov 09 2015
AMSC Resilient Electric Grid System Program Moves Forward With New Funding Authorization Nov 03 2015
AMSC Reports Second Quarter Fiscal 2015 Financial Results and Provides Business Outlook Nov 03 2015
AMSC to Report Second Quarter Financial Results on November 3, 2015 Oct 28 2015
Anglo American defers platinum investment decisions, cuts diamond output Oct 22 2015
Anglo American defers platinum investment decisions, cuts diamond output Oct 22 2015
Platinum fails to fill breach left by gold in South Africa Oct 21 2015
Zimbabwe threatens to re-impose platinum tax if miners don't process locally Oct 15 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK